An autism spectrum disorder-related de novo mutation hotspot discovered in the GEF1 domain of Trio
Trio is a RhoGEF protein that promotes actin polymerization and is implicated in the regulation of glutamatergic synapses in autism spectrum disorder (ASD). Here the authors identify a large cluster of de novo mutations in the GEF1 domain of Trio in whole-exome sequencing data from individuals with...
Main Authors: | Anastasiia Sadybekov, Chen Tian, Cosimo Arnesano, Vsevolod Katritch, Bruce E. Herring |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2017-09-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-017-00472-0 |
Similar Items
-
Detection of autism spectrum disorder-related pathogenic trio variants by a novel structure-based approach
by: Sadhna Rao, et al.
Published: (2024-04-01) -
An Intellectual Disability-Related Missense Mutation in Rac1 Prevents LTP Induction
by: Chen Tian, et al.
Published: (2018-07-01) -
Synaptic Kalirin-7 and Trio Interactomes Reveal a GEF Protein-Dependent Neuroligin-1 Mechanism of Action
by: Jeremiah D. Paskus, et al.
Published: (2019-12-01) -
The RhoGEF Trio: A Protein with a Wide Range of Functions in the Vascular Endothelium
by: Lanette Kempers, et al.
Published: (2021-09-01) -
Trio, a Rho Family GEF, Interacts with the Presynaptic Active Zone Proteins Piccolo and Bassoon.
by: Ryan T Terry-Lorenzo, et al.
Published: (2016-01-01)